Atlas Trials

Randomized Clinical Trial of Intranasal Dexamethasone as an Adjuvant in Patients With COVID-19

Clinical trial NCT04513184 · COMPLETED

Trial details

NCT number
NCT04513184
Sponsor
Edda Sciutto Conde
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Covid19
Start date
2021-11-05
Primary completion
2021-11-12
Enrollment
66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.